Having established the conditions necessary to induce the formation of tau inclusions in hTau primary neurons, we tested how the model responded to molecules aimed at preventing tau aggregation, as these are the focus of many therapeutic approaches for Tauopathies. Here, MAPT is linked to tauopathy.